Expression profiling of immune inhibitory Siglecs and their ligands in patients with glioma-Reference-Cited by-同舟云学术

Expression profiling of immune inhibitory Siglecs and their ligands in patients with glioma

Published:2019-04-05 Issue:6 Volume:68 Page:937-949
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Santegoets Kim C. M.,Gielen Paul R.,Büll Christian,Schulte Barbara M.,Kers-Rebel Esther D.,Küsters Benno,Bossman Sandra A. J. F. H.,ter Laan Mark,Wesseling Pieter,Adema Gosse J.

Funder

STOPbraintumors Foundation

European Cooperation in Science and Technology

Radboud Universitair Medisch Centrum

Radboud Institute for Oncology

KWF Kankerbestrijding

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-019-02332-w.pdf

Reference44 articles.

1. Gielen PR (2016) The immunosuppressive network in patients with glioma; focus on the role of myeloid derived suppressor cells (doctoral thesis). Radboud umc, Nijmegen

2. Ho VK, Reijneveld JC, Enting RH, Bienfait HP, Robe P, Baumert BG, Visser O, Dutch Society for N-O (2014) Changing incidence and improved survival of gliomas. Eur J Cancer 50(13):2309–2318. https://doi.org/10.1016/j.ejca.2014.05.019

3. Sarkaria JN, Kitange GJ, James CD, Plummer R, Calvert H, Weller M, Wick W (2008) Mechanisms of chemoresistance to alkylating agents in malignant glioma. Clin Cancer Res 14(10):2900–2908. https://doi.org/10.1158/1078-0432.CCR-07-1719

4. Gousias K, Markou M, Arzoglou V, Voulgaris S, Vartholomatos G, Kostoula A, Voulgari P, Polyzoidis K, Kyritsis AP (2010) Frequent abnormalities of the immune system in gliomas and correlation with the WHO grading system of malignancy. J Neuroimmunol 226(1–2):136–142. https://doi.org/10.1016/j.jneuroim.2010.05.027

5. Grauer OM, Wesseling P, Adema GJ (2009) Immunotherapy of diffuse gliomas: biological background, current status and future developments. Brain Pathol 19(4):674–693. https://doi.org/10.1111/j.1750-3639.2009.00315.x

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Siglec‐7 and Siglec‐9 expression in primary triple negative and oestrogen receptor positive breast cancer and in vitro signalling;Clinical & Translational Immunology;2024-09

2. High expression of SIGLEC7 may promote M2-type macrophage polarization leading to adverse prognosis in glioma patients;Frontiers in Immunology;2024-08-15

3. The Role of Clycodelin in Conversion of CD11b+ Cells to MDSCs and Regulation of Their Functional Activity;Cell and Tissue Biology;2024-08

4. Insights of immune cell heterogeneity, tumor-initiated subtype transformation, drug resistance, treatment and detecting technologies in glioma microenvironment;Journal of Advanced Research;2024-08

5. Fast Metabolic Glycan Labeling for Click-Labeling and Imaging of Sialoglycans in Living Acute Brain Slices from Mice and Human Patients;Journal of the American Chemical Society;2024-07-30